Citation tools
"Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Carcinoid Heart Disease: A Contraindication or a Promising Treatment Approach Bettering Chances for Corrective Surgery?." Journal of Nuclear Medicine Technology
46.3
(2018):
292-294.
Web. 25 April. 2025.